lcp
We have detected you are using Internet Explorer. To provide the best and most secure experience, please use a modern browser as we do not support Internet Explorer.

Unveiling Ovarian Cancer - It’s time to raise awareness

29 February 2024 - Susan Helmrich

How can we shed light on the challenges and diagnostic journey of patients?

Fran's Case

Fran's symptoms included abdominal bleeding, lower abdominal pain, pain in the lower rectum, super pubic area discomfort, epigastric pain, nausea, decreased appetite, and irregular periods. The initial diagnosis leaned towards constipation and gastritis linked to stress and lifestyle. However, a follow-up examination revealed persisting symptoms, leading to a broader investigation, including stool samples, blood tests, and a CT scan.

The Turning Point

The CT scan exposed a large ovarian mass highly suggestive of ovarian carcinoma, coupled with ascites. Fran was swiftly admitted to the hospital, underwent ascites drainage, and commenced preoperative chemotherapy. The diagnosis extended to lung and peritoneal metastases, and Fran faced a major post-op complication. Despite ongoing palliative chemotherapy, her prognosis remains grim.

Understanding Ovarian Cancer

Ovarian cancer, as highlighted by Cancer Australia ranks as the ninth most common cancer in Australian women and the sixth leading cause of cancer death. The disease carries a lower five-year survival rate compared to other cancers. Risk factors include age over fifty, genetic predisposition, family history, endometriosis, smoking, and hormone therapy use.

Symptoms and Challenges in Ovarian Cancer Diagnosis

The challenge in diagnosing ovarian cancer lies in its vague symptoms, such as abdominal bloating, indigestion, lack of appetite, and fatigue. These symptoms often mimic common issues and can lead to delayed diagnosis, as seen in Fran's case. Ovarian cancer should be considered in women over forty with persistent symptoms lasting more than four weeks.

Key Takeaways and Recommendations:

  1. Clinical Examination: Performing both pelvic and abdominal examinations, especially in women over forty, is crucial. Fran's case highlighted the potential impact of early detection through pelvic examination.

  2. Imaging: A low threshold for pelvic imaging, particularly transvaginal ultrasound, is recommended for suspected cases. Imaging can aid in identifying pelvic masses and guide further investigations.

  3. Risk Factors: Understanding risk factors, such as genetic predisposition and endometriosis, can help in early identification of potential cases.

  4. Screening: Routine screening for ovarian cancer is not recommended for the general population. The webinar stressed the lack of evidence supporting the effectiveness of screening in improving mortality rates.

  5. Awareness: Healthcare professionals should maintain a heightened awareness of ovarian cancer in women over forty with new or persistent abdominal symptoms.

The Challenge

Diagnosing ovarian cancer due to its non-specific symptoms can be supported by increased awareness. Healthcare practitioners must maintain a vigilant approach, considering ovarian cancer in the differential diagnosis for women presenting with persistent symptoms.

Early detection remains crucial for improving outcomes and enhancing the quality of life for individuals facing this challenging diagnosis. Raising awareness and encouraging patients to keep a symptom journal can help with early recognition and diagnosis to help reduce the mortality of this cancer.

Related Courses

Ovarian Cancer - Clinical Practice Review

Women's Health in General Practice

References

Optimal care pathway for women with ovarian cancer 2nd edition 2021 https://www.cancer.org.au/assets/pdf/ovarian-cancer-2nd-edition

Clinical practice guideline - Australian Government 2011 https://canceraustralia.gov.au/sites/default/files/__migrated_guidelines/guideline_14.pdf

Quick reference guide https://www.cancer.org.au/assets/pdf/ovarian-cancer-quick-reference-guide 

Optimal tumour tissue collection in newly diagnosed, advanced ovarian, fallopian tube and primary peritoneal cancer patients https://www.datocms-assets.com/102334/1705629097-oca-tumour-testing-guidelines-0124-final.pdf 

Patient information https://www.cancer.org.au/assets/pdf/ovarian-cancer-english 

Susan Helmrich
Susan Helmrich

Susan is the Head of Nursing Education for the Medcast Group.

DipAppScNsg, BN, CritCareCert, CoronaryCareCert, TraumaNsgCareCert, CertIV(TAE), MN(Ed), and GradCert(Ldrshp & Mgt).

Get Medcast Plus

Become a member and get unlimited access to 100s of hours of premium education.

Learn more
Latest News
My patients are concerned about the safety of topical corticosteroids – should they be?
Brand icon

Stories about topical steroid withdrawal are difficult to put into context for both consumers and health professionals. The outcome is that many consumers are avoiding using topical corticosteroids, which in many cases, makes it harder to manage conditions such as eczema.

5 mins READ
Obstetric Emergencies, can you help Lauren?

You are working in ED and have received a call from Pathology regarding blood results that you took earlier on Lauren, who is 18 years old and 30 weeks pregnant with her first child. Discover the diagnosis behind Lauren's abnormal blood results and learn the symptoms, risks, and management of this life-threatening obstetric emergency.

5 mins READ
Navigating the Eczema Journey
Brand icon

Jaime has suffered from severe eczema for most of his life. This podcast delves into the interactions that take place between consumers and health professionals in the eczema journey. 

36 mins READ